Della Terra’s product portfolio focuses on plant and fungi-derived pharmaceuticals. We are continually researching and developing new pharmaceutical medicines based on botanical-derived compounds.
Opiod Use Disorder
Phase 1 study complete. Phase 2 study planned.
Pre-Clinical study complete
Pre-Clinical study complete
Energy / Fatigue & Pain
Preparing for NDIN Submission
Energy / Fatigue & Pain
CMC in Progress
Energy / Fatigue & Pain
CMC in Progress
CMC Planned
CMC Planned
Della Terra Pharmaceuticals continually seeks scientific partners to strengthen our portfolio and advance our mission. We actively seek opportunities to collaborate with other companies, academia, patient advocacy groups, and industry stakeholders to develop and commercialize new products or license existing assets.
Let’s Connect
